打开网易新闻 查看精彩图片
打开网易新闻 查看精彩图片
打开网易新闻 查看精彩图片
打开网易新闻 查看精彩图片
打开网易新闻 查看精彩图片
打开网易新闻 查看精彩图片
打开网易新闻 查看精彩图片
打开网易新闻 查看精彩图片
打开网易新闻 查看精彩图片
打开网易新闻 查看精彩图片
打开网易新闻 查看精彩图片
打开网易新闻 查看精彩图片
打开网易新闻 查看精彩图片
打开网易新闻 查看精彩图片
打开网易新闻 查看精彩图片
打开网易新闻 查看精彩图片
打开网易新闻 查看精彩图片
打开网易新闻 查看精彩图片
打开网易新闻 查看精彩图片
打开网易新闻 查看精彩图片
打开网易新闻 查看精彩图片
打开网易新闻 查看精彩图片
打开网易新闻 查看精彩图片
打开网易新闻 查看精彩图片
打开网易新闻 查看精彩图片
打开网易新闻 查看精彩图片
打开网易新闻 查看精彩图片
打开网易新闻 查看精彩图片
打开网易新闻 查看精彩图片
打开网易新闻 查看精彩图片

Join Dana-Farber Cancer Institute for the 2nd International NUT Carcinoma Research Symposium, a timely meeting of clinical and translational oncology leaders. Sponsored by the NUT Carcinoma Alliance, this symposium aims to share critical research updates, develop consensus treatment guidelines, and set the national agenda for clinical trials, positioning NUT carcinoma research for its next breakthrough moment.

SYMPOSIUM AGENDA(Subject to Change)

8:00 AM. Breakfast and Registration8:30 AM. Introductory PresentationsWelcome and IntroductionJia Luo, MD, Dana-Farber Cancer Institute (DFCI)Christopher A. French, MD, Brigham and Women’s Hospital (BWH)Geoffrey Shapiro, MD, PhD, DFCI

  • Introduction to NUT Carcinoma: Background and Science – Christopher A. French, MD, BWH

  • Patient Perspective and Interview – Maddie Woepse, The Patrick Woepse Foundation

  • NUT Carcinoma Registry Update: Informing Clinical Care and Translational Research – Jia Luo, MD, DFCI

  • Next Generation Diagnostics in NC Diagnosis – John Iafrate, MD, PhD, MGH

9:35 AM. Break and Group Photo9:45 AM. Developing NUT Carcinoma Treatment Guidelines (Panel Discussion)Chairs: Jia Luo, MD, DFCI; Steven Dubois, MD, MS, DFCI; Benjamin H. Kann, MD, BWH; Hassan A. Khalil, MD, BWH; Michael Dennis, MD, DFCI

  • Thoracic Medical Oncology – Jia Luo, MD, DFCI; and Robert Hsu, MD, Keck School of Medicine at USC

  • Head and Neck Oncology – Michael Dennis, MD, DFCI

  • Pediatrics – Steven Dubois, MD, MS, DFCI and Boston Children’s Hospital; and Michael V. Ortiz, MD, MSKCC

  • Pathology – Lynette M. Sholl, MD, DFCI

  • Thoracic Surgery – Hassan A. Khalil, MD, BWH

  • ENT Surgery – Rosh K. Sethi, MD, MPH, DFCI

  • Thoracic Radiation Oncology – Benjamin H. Kann, MD, BWH

  • Investigational Cancer Therapeutics – Sarina A. Piha-Paul, MD Anderson Cancer Center at the University of Texas (MDACC)

  • ENT Radiation Oncology – Roy Tishler, DFCI

  • Nursing Professionals – Stephanie Canty, CNP, DFCI and Samantha Janell, BSN, RN, DFCI

11:15 AM. Future Directions Part OneChair: Kyle P. Eagen, PhD, Baylor College of Medicine

  • GENOME ORIGAMI: DNA Misfolding in NUT Carcinoma – Kyle P. Eagen, PhD, Baylor College of Medicine

  • BD2-selective inhibition is a unique vulnerability in NUT carcinoma – Christopher A. French, MD, BWH

  • Exploiting replicative stress in NUT carcinoma with ATR inhibition – Daryl Griffin, Laboratory of Geoffrey Shapiro, MD, PhD, DFCI

  • Transcriptional Chemical Inducers of Proximity (TCIPs) in NUT carcinoma – Hayden Malone, PhD, Laboratory of Jerry Crabtree, Stanford University

1:00 PM Lunch and Keynote AddressKeynote Speaker: George Demetri, DFCIIntroduced by Geoffrey Shapiro, MD, PhD, DFCI2:00 PM. Future Directions Part TwoChair: Hassan A. Khalil, MD, BWH

  • Tumor Microenvironment (TME) – James Brenner, DFCI

  • Immune Therapy/Cancer Vaccination – Derin Keskin, DFCI

  • PRAME and Other NC Epitopes – Alex Rubinsteyn, PhD, UNC School of Medicine

  • Antibody Drug Conjugates – Juyoung Choi, The Choi Lab at Samsung Advanced Institute for Health Sciences & Technology (SAIHST), Sungkyunkwan University; Laboratory of Molecular and Digital Pathology for Theranostics

3:40 PM. Break3:45 PM. Setting the Clinical Trials Agenda for NUT Carcinoma (Panel Discussion)Chairs: Michael Dennis, MD, DFCI; Geoffrey Shapiro, MD, PhD, DFCI

Lorraine Pelosof, MD, PhD, National Cancer Institute

Jia Luo, MD, DFCIGeoffrey Shapiro, MD, PhD, DFCI

Sarina A. Piha-Paul, MDACC

Jochen Lorch, MD, Northwestern Medicine

Kartik Sehgal, MD, DFCI

4:45 PM. Closing Remarks

Geoffrey Shapiro, MD, PhD, DFCI

Skip Victor, Patient Advocate

5:00 PM. Reception and Networking6:00 PM. End of Day

This event is sponsored by the NUT Carcinoma Alliance.